Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
25 April 2013Website:
http://glucotrack.comNext earnings report:
15 May 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 21 Nov 2024 00:08:46 GMTDividend
Analysts recommendations
Institutional Ownership
GCTK Latest News
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a “best efforts” public offering of 2,437,340 shares of common stock and 4,756,900 pre-funded warrants, with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $1.389. The gross proceeds of the public offering were approximately $10 million before deducting placement agent fees and offering expenses.
Updated preclinical data for the continuous blood glucose monitor to be presented at major diabetes technology conference
Glucotrack ADCES poster highlights over 50% of surveyed diabetes patients are open to new Continuous Blood Glucose Monitor concept
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the Sidoti Small Cap Investor Conference.
GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it's planning for a firm commitment underwritten public offering.
What type of business is GlucoTrack?
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
What sector is GlucoTrack in?
GlucoTrack is in the Healthcare sector
What industry is GlucoTrack in?
GlucoTrack is in the Medical Instruments & Supplies industry
What country is GlucoTrack from?
GlucoTrack is headquartered in United States
When did GlucoTrack go public?
GlucoTrack initial public offering (IPO) was on 25 April 2013
What is GlucoTrack website?
https://glucotrack.com
Is GlucoTrack in the S&P 500?
No, GlucoTrack is not included in the S&P 500 index
Is GlucoTrack in the NASDAQ 100?
No, GlucoTrack is not included in the NASDAQ 100 index
Is GlucoTrack in the Dow Jones?
No, GlucoTrack is not included in the Dow Jones index
When was GlucoTrack the previous earnings report?
No data
When does GlucoTrack earnings report?
The next expected earnings date for GlucoTrack is 15 May 2025